Capital International Sarl’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,011
Closed -$354K 296
2025
Q4
$354K Hold
1,011
0.01% 287
2025
Q3
$327K Sell
1,011
-967
-49% -$301K 0.01% 272
2025
Q2
$769K Buy
1,978
+103
+5% +$41.4K 0.01% 256
2025
Q1
$816K Buy
1,875
+846
+82% +$340K 0.02% 253
2024
Q4
$380K Buy
1,029
+254
+33% +$106K 0.01% 266
2024
Q3
$403K Buy
775
+258
+50% +$138K 0.01% 259
2024
Q2
$280K Buy
+517
New +$273K 0.01% 259
2023
Q3
Sell
-4,840
Closed -$2.15M 225
2023
Q2
$2.15M Hold
4,840
0.1% 172
2023
Q1
$2.23M Buy
+4,840
New +$2.3M 0.11% 167
2022
Q2
Sell
-6,278
Closed -$3.08M 225
2022
Q1
$3.08M Sell
6,278
-1,343
-18% -$614K 0.15% 153
2021
Q4
$3.53M Buy
7,621
+838
+12% +$353K 0.17% 139
2021
Q3
$2.53M Sell
6,783
-665
-9% -$253K 0.22% 113
2021
Q2
$2.84M Sell
7,448
-1,066
-13% -$407K 0.25% 110
2021
Q1
$3.06M Sell
8,514
-303
-3% -$97.4K 0.29% 99
2020
Q4
$2.83M Sell
8,817
-65
-0.7% -$19.9K 0.3% 98
2020
Q3
$2.39M Sell
8,882
-7,101
-44% -$1.91M 0.29% 92
2020
Q2
$4.2M Buy
15,983
+248
+2% +$66.2K 0.56% 53
2020
Q1
$3.57M Sell
15,735
-405
-3% -$110K 0.65% 46
2019
Q4
$4.88M Buy
16,140
+11,350
+237% +$3.12M 0.76% 47
2019
Q3
$1.15M Buy
4,790
+1,190
+33% +$326K 0.2% 118
2019
Q2
$1.02M Buy
+3,600
New +$983K 0.14% 117

Other funds holding ELV

Capital International Sarl's ELV Position: Q1 2026 in Review

Capital International Sarl sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,011 shares — an estimated $354K sold.

Capital International Sarl first reported a position in ELV in Q2 2019 and held it in 21 quarters. The position peaked at $4.88M in Q4 2019. 1,469 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Capital International Sarl reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Capital International Sarl sold 1,011 Elevance Health shares in Q1 2026, an estimated $354K.
  • Capital International Sarl first reported a position in Elevance Health in Q2 2019 and held it in 21 quarters.
  • Capital International Sarl's Elevance Health position peaked at $4.88M in Q4 2019.
  • 1,469 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Capital International Sarl's 13F filing for Q1 2026, filed 13 May 2026.